Shuang-Shuang Dai

Prof. Shuang-Shuang Dai


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
YLYang-Wuyue Liu
Yang-Wuyue Liu
JZJingyu Zhang
Jingyu Zhang
WBWanda Bi
Wanda Bi
MZMi Zhou
Mi Zhou
JLJiabo Li
Jiabo Li
SDShuang-Shuang Dai
Shuang-Shuang Dai

24 April 2022 in Cancer Science
Verified
Journal Article
Open access
TXTiantian Xiong
Tiantian Xiong
PHPing He
Ping He
MZMi Zhou
Mi Zhou
DZDan Zhong
Dan Zhong
TYTeng Yang
Teng Yang
SDShuang-Shuang Dai
Shuang-Shuang Dai
Neutrophils are the first defenders of the innate system for injury and infection. They have gradually been recognized as important participants in tumor initiation and development due to their heterogeneity and plasticity. In the tumor microenvironment (TME), neutrophils can exert antitumor and protumor functions, depending on the surroundings. Tumor cells systemically alter intracellular amino acid (AA) metabolism and extracellular AA distribution to meet their proliferation need, leading to metabolic reprogramming and TME reshaping. However, the underlying mechanisms that determine how altered AAs affect neutrophils in TME are less‐explored. Here, we identified that abundant glutamate releasing from tumor cells blunted neutrophils’ cell‐killing effects toward tumor cells in vitro and in vivo. Mass spectrometric detection, flow cytometry, and western blot experiments proved that increased levels of pSTAT3/RAB10/ARF4, mediated by glutamate, were accompanied with immunosuppressive phenotypes of neutrophils in TME. We also discovered that riluzole, an FDA‐approved glutamate release inhibitor, significantly inhibited tumor growth by restoring neutrophils’ cell‐killing effects and decreasing glutamate secretion from tumor cells. These findings highlight the importance of tumor‐released glutamate on neutrophil transformation in TME, providing new possible cancer treatments targeting altered glutamate metabolism.

1 July 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
YLYang-Wuyue Liu
Yang-Wuyue Liu
LZLi Zhao
Li Zhao
MZMi Zhou
Mi Zhou
HWHao Wang
Hao Wang
NYNan Yang
Nan Yang
SDShuang-Shuang Dai
Shuang-Shuang Dai

6 July 2023 in Biochemistry and Molecular Biology Education
Verified
Journal Article
Closed access
DZDan Zhong
Dan Zhong
YLYang‐Wuyue Liu
Yang‐Wuyue Liu
GHGang Huang
Gang Huang
ZXZhizhen Xu
Zhizhen Xu
YZYuanyin Zhao
Yuanyin Zhao
SDShuang-Shuang Dai
Shuang-Shuang Dai

24 July 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RZRuitian Zhou
Ruitian Zhou
TZTong Zhang
Tong Zhang
JSJianbin Sun
Jianbin Sun
MTMenglan Tan
Menglan Tan
TLTao Li
Tao Li
YLYang-Wuyue Liu
Yang-Wuyue Liu

13 January 2024 in Experimental Neurology
Verified
Journal Article
Closed access
JRJiakui Ren
Jiakui Ren
TYTeng Yang
Teng Yang
HLHeting Liu
Heting Liu
PMPengjiao Ma
Pengjiao Ma
MZMi Zhou
Mi Zhou
YLYang-Wuyue Liu
Yang-Wuyue Liu